61 related articles for article (PubMed ID: 16595331)
1. Effect of millimeter waves on cyclophosphamide induced NF-kappaB.
Logani MK; Natarajan M; Makar VR; Bhanushali A; Ziskin MC
Electromagn Biol Med; 2006; 25(1):23-7. PubMed ID: 16595331
[TBL] [Abstract][Full Text] [Related]
2. Effect of millimeter waves and cyclophosphamide on cytokine regulation.
Logani MK; Alekseev S; Bhopale MK; Slovinsky WS; Ziskin MC
Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):107-12. PubMed ID: 21649551
[TBL] [Abstract][Full Text] [Related]
3. Effect of millimeter waves on natural killer cell activation.
Makar VR; Logani MK; Bhanushali A; Kataoka M; Ziskin MC
Bioelectromagnetics; 2005 Jan; 26(1):10-9. PubMed ID: 15605409
[TBL] [Abstract][Full Text] [Related]
4. Effect of millimeter wave irradiation on tumor metastasis.
Logani MK; Szabo I; Makar V; Bhanushali A; Alekseev S; Ziskin MC
Bioelectromagnetics; 2006 May; 27(4):258-64. PubMed ID: 16437545
[TBL] [Abstract][Full Text] [Related]
5. Maternal immunopotentiation affects caspase activation and NF-kappaB DNA-binding activity in embryos responding to an embryopathic stress.
Torchinsky A; Gongadze M; Zaslavsky Z; Savion S; Fein A; Toder V
Am J Reprod Immunol; 2006 Jan; 55(1):36-44. PubMed ID: 16364010
[TBL] [Abstract][Full Text] [Related]
6. A high dose of ionizing radiation induces tissue-specific activation of nuclear factor-kappaB in vivo.
Zhou D; Brown SA; Yu T; Chen G; Barve S; Kang BC; Thompson JS
Radiat Res; 1999 Jun; 151(6):703-9. PubMed ID: 10360790
[TBL] [Abstract][Full Text] [Related]
7. Effect of millimeter waves on cyclophosphamide induced suppression of T cell functions.
Makar V; Logani M; Szabo I; Ziskin M
Bioelectromagnetics; 2003 Jul; 24(5):356-65. PubMed ID: 12820293
[TBL] [Abstract][Full Text] [Related]
8. Effect of cyclophosphamide and 61.22 GHz millimeter waves on T-cell, B-cell, and macrophage functions.
Makar VR; Logani MK; Bhanushali A; Alekseev SI; Ziskin MC
Bioelectromagnetics; 2006 Sep; 27(6):458-66. PubMed ID: 16622862
[TBL] [Abstract][Full Text] [Related]
9. Combined millimeter wave and cyclophosphamide therapy of an experimental murine melanoma.
Logani MK; Bhanushali A; Anga A; Majmundar A; Szabo I; Ziskin MC
Bioelectromagnetics; 2004 Oct; 25(7):516-23. PubMed ID: 15376243
[TBL] [Abstract][Full Text] [Related]
10. NF-kappa B DNA-binding activity in embryos responding to a teratogen, cyclophosphamide.
Torchinsky A; Lishanski L; Wolstein O; Shepshelovich J; Orenstein H; Savion S; Zaslavsky Z; Carp H; Brill A; Dikstein R; Toder V; Fein A
BMC Dev Biol; 2002; 2():2. PubMed ID: 11893254
[TBL] [Abstract][Full Text] [Related]
11. Differential teratogenic response of TNFalpha+/+ and TNFalpha-/- mice to cyclophosphamide: the possible role of NF-kappaB.
Torchinsky A; Gongadze M; Savion S; Fein A; Toder V
Birth Defects Res A Clin Mol Teratol; 2006 Jun; 76(6):437-44. PubMed ID: 16933209
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells.
Li Y; Ahmed F; Ali S; Philip PA; Kucuk O; Sarkar FH
Cancer Res; 2005 Aug; 65(15):6934-42. PubMed ID: 16061678
[TBL] [Abstract][Full Text] [Related]
13. p53 regulates cyclophosphamide teratogenesis by controlling caspases 3, 8, 9 activation and NF-kappaB DNA binding.
Pekar O; Molotski N; Savion S; Fein A; Toder V; Torchinsky A
Reproduction; 2007 Aug; 134(2):379-88. PubMed ID: 17660247
[TBL] [Abstract][Full Text] [Related]
14. [Role of NF-kappa B in cancer cachexia].
Zhou W; Jiang ZW; Jiang J; Li N; Li JS
Zhonghua Wai Ke Za Zhi; 2004 Jun; 42(11):683-6. PubMed ID: 15329260
[TBL] [Abstract][Full Text] [Related]
15. Apigenin potentiates the growth inhibitory effects by IKK-β-mediated NF-κB activation in pancreatic cancer cells.
Wu DG; Yu P; Li JW; Jiang P; Sun J; Wang HZ; Zhang LD; Wen MB; Bie P
Toxicol Lett; 2014 Jan; 224(1):157-64. PubMed ID: 24148603
[TBL] [Abstract][Full Text] [Related]
16. KINK-1, a novel small-molecule inhibitor of IKKbeta, and the susceptibility of melanoma cells to antitumoral treatment.
Schön M; Wienrich BG; Kneitz S; Sennefelder H; Amschler K; Vöhringer V; Weber O; Stiewe T; Ziegelbauer K; Schön MP
J Natl Cancer Inst; 2008 Jun; 100(12):862-75. PubMed ID: 18544741
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of histamine H4 receptors contributes to splenic apoptosis in septic mice: counteraction of the antiapoptotic action of nuclear factor-kappaB.
Matsuda N; Teramae H; Futatsugi M; Takano K; Yamamoto S; Tomita K; Suzuki T; Yokoo H; Koike K; Hattori Y
J Pharmacol Exp Ther; 2010 Mar; 332(3):730-7. PubMed ID: 20008488
[TBL] [Abstract][Full Text] [Related]
18. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
[TBL] [Abstract][Full Text] [Related]
19. Cepharanthin-enhanced radiosensitivity through the inhibition of radiation-induced nuclear factor-kappaB activity in human oral squamous cell carcinoma cells.
Tamatani T; Azuma M; Motegi K; Takamaru N; Kawashima Y; Bando T
Int J Oncol; 2007 Oct; 31(4):761-8. PubMed ID: 17786306
[TBL] [Abstract][Full Text] [Related]
20. Diarctigenin, a lignan constituent from Arctium lappa, down-regulated zymosan-induced transcription of inflammatory genes through suppression of DNA binding ability of nuclear factor-kappaB in macrophages.
Kim BH; Hong SS; Kwon SW; Lee HY; Sung H; Lee IJ; Hwang BY; Song S; Lee CK; Chung D; Ahn B; Nam SY; Han SB; Kim Y
J Pharmacol Exp Ther; 2008 Nov; 327(2):393-401. PubMed ID: 18694995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
